rotenone has been researched along with Body Weight in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (14.29) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 7 (20.00) | 29.6817 |
| 2010's | 18 (51.43) | 24.3611 |
| 2020's | 3 (8.57) | 2.80 |
| Authors | Studies |
|---|---|
| El-Naga, RN; Mohamad, KA; Wahdan, SA | 1 |
| Gurke, R; Manderscheid, C; Niederberger, E; Schreiber, Y; Tegeder, I; Wilken-Schmitz, A | 1 |
| Khurana, N; Muthuraman, A; Sharma, N; Utreja, P | 1 |
| Ellinger-Ziegelbauer, H; Freyberger, A; Heinz, S; Lawrenz, B; Schladt, L; Schmuck, G | 1 |
| Azmy, MS; El-Naga, RN; Menze, ET; Tadros, MG | 1 |
| Costa, SL; da Silva, VDA; Fonseca-Fonseca, LA; Montano-Peguero, Y; Núñez-Figueredo, Y; Padrón Yaquis, AS; Pardo-Andreu, GL; Ramírez-Sánchez, J; Rodríguez, AM; Wong-Guerra, M | 1 |
| Chen, CL; Chen, YR; Chilian, WM; Dyck, JR; Enrick, M; Hardwick, JP; Kolz, C; Pung, YF; Sam, WJ; Stevanov, K; Thakker, P; Yin, L | 1 |
| Fechtali, T; Filali-Zegzouti, Y; Rouanet, JL; Roussel, D | 1 |
| Bensimon, C; Duan, Y; Fernando, P; Glenn Wells, R; Lockwood, J; Mullett, WM; Ruddy, T; Wei, L; Yan, X | 1 |
| Nehru, B; Thakur, P | 1 |
| Abdallah, DM; Al-Shorbagy, MY; Arab, HH; Nassar, NN | 1 |
| Chen, NH; Chu, SF; Li, J; Liu, Y; Song, LK; Sun, JD; Yuan, YH | 1 |
| El-Horany, HE; El-Latif, RN; ElBatsh, MM; Emam, MN | 1 |
| Feng, D; Gong, J; He, X; Ji, J; Jin, T; Li, L; Liu, C; Sun, H; Sun, J; Xiang, L; Yue, S; Zhou, R | 1 |
| Cai, DF; Cai, M; Li, WW; Li, XT; Wu, T; Xiang, J; Yu, ZH; Zhang, JS; Zhang, W; Zhang, ZN | 1 |
| Chesselet, MF; Dicarlo, CD; Elashoff, D; Fernagut, PO; Fleming, SM; Hsia, YC; Meurers, BH; Oh, M; Richter, F; Seaman, RL; Zhu, C | 1 |
| Cannon, JR; Drolet, RE; Greenamyre, JT; Montero, L | 1 |
| Cannon, JR; Greenamyre, JT; Tapias, V | 1 |
| Cuenca, N; De Juan, E; Esteve-Rudd, J; Fernández-Sánchez, L; Lax, P; Martín-Nieto, J | 1 |
| Cai, Z; Fan, LW; Lin, RC; Rhodes, PG; Simpson, KL; Tien, LT | 1 |
| Erbaş, O; Oltulu, F; Taşkiran, D | 1 |
| Chaves, RS; D'unhao, AM; Farizatto, KL; Ferrari, MF; Martins, SA; Melo, TQ | 1 |
| Antkiewicz-Michaluk, L; Bojarski, AJ; Karolewicz, B; Michaluk, J; Romańska, I; Vetulani, J | 1 |
| Gu, W; Huang, J; Li, Y; Liu, H; Xu, Z; Yan, Z; Yang, Y; Zhu, X | 1 |
| Champy, P; Duyckaerts, C; Féger, J; Hirsch, EC; Höglinger, GU; Khondiker, ME; Lannuzel, A; Lombes, A; Medja, F; Michel, PP; Oertel, WH; Prigent, A; Ruberg, M | 1 |
| Benedí, J; Elorza, M; Gómez del Rio, MA; Iglesias, I; Sánchez-Reus, MI; Slowing, K | 1 |
| Sing, LT; Spencer, F | 1 |
| Allaben, WT; Burger, GT; Greenman, DL; Kodell, RL | 1 |
| Ayoubi, SA; Isenberg, JS; Klaunig, JE; Kolaja, KL; Watkins, JB | 1 |
| Bourobou Bourobou, HP; Ibrahim, B; M'batchi, B; Mounzeo, H; Posso, P | 1 |
| Drahota, Z; Zeit-Har, SA | 1 |
| Abdo, KM; Eustis, SL; Haseman, J; Huff, JE; Persing, R; Peters, A | 1 |
| Peter, JB; Verhaag, DA; Worsfold, M | 1 |
| Figueras, MJ; Gosalvez, M | 1 |
| Chudapongse, N; Kamonwannasit, S; Kumkrai, P | 1 |
35 other study(ies) available for rotenone and Body Weight
| Article | Year |
|---|---|
Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway.
Topics: alpha-Synuclein; Animals; Body Weight; Catalepsy; Dopamine; Indoles; Male; MAP Kinase Signaling System; Motor Activity; Neostriatum; Neuroprotective Agents; Parkinson Disease, Secondary; Postural Balance; Rats; Rats, Sprague-Dawley; Rotenone; Sirtuin 1; Tyrosine 3-Monooxygenase; Uncoupling Agents | 2022 |
Non-Reproducibility of Oral Rotenone as a Model for Parkinson's Disease in Mice.
Topics: alpha-Synuclein; Animals; Body Weight; Chromatography, Liquid; Disease Models, Animal; Mice; Mice, Inbred C57BL; Parkinson Disease; Parkinsonian Disorders; Rotenone; Substantia Nigra; Tandem Mass Spectrometry | 2022 |
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model.
Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Body Weight; Carbidopa; Catalase; Catalepsy; Disease Models, Animal; Dopamine; Drug Combinations; Female; Glutathione; Levodopa; Locomotion; Male; Mesencephalon; Muscular Diseases; Oxidative Stress; Parkinson Disease; Postural Balance; Rats, Sprague-Dawley; Rotenone; Superoxides; Thiobarbituric Acid Reactive Substances; Vanillic Acid | 2021 |
Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation.
Topics: Administration, Oral; Animals; Body Weight; Bone and Bones; Brain; Electron Transport Complex I; Gene Expression; Hematopoiesis; Liver; Male; Mitochondria; Rats; Rats, Wistar; Rotenone | 2017 |
Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents; Apoptosis; bcl-2-Associated X Protein; Body Weight; Corpus Striatum; Filgrastim; Humans; Inflammation; Male; Mesencephalon; Microglia; Motor Activity; Nerve Growth Factors; Neuroprotective Agents; Parkinson Disease; Rats, Wistar; Rotenone; Tyrosine 3-Monooxygenase | 2018 |
JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
Topics: Animals; Benzodiazepines; Body Weight; Brain; Catalase; Cell Death; Cells, Cultured; Humans; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Niacin; Oxidative Stress; Rats; Rotenone; Superoxide Dismutase | 2019 |
Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-α signaling.
Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Endothelial Cells; Humans; Ischemia; Mitochondria; Myocardium; Oxidative Stress; Rats; Rats, Inbred WKY; Rotenone; Signal Transduction; TOR Serine-Threonine Kinases; Uncoupling Agents | 2013 |
Mitochondrial oxidative energy metabolism in guanethidine-induced sympathectomized ducklings.
Topics: Animals; Antimycin A; Ascorbic Acid; Body Weight; Catecholamines; Ducks; Fatty Acids; Glucose; Guanethidine; Heart Rate; Male; Mitochondria; Oxidative Phosphorylation; Oxygen; Rotenone; Sarcolemma; Succinic Acid; Tetramethylphenylenediamine; Uncoupling Agents | 2014 |
Toxicological evaluation of a rotenone derivative in rodents for clinical myocardial perfusion imaging.
Topics: Animals; Biomarkers; Body Weight; Cells, Cultured; Echocardiography; Female; Hepatocytes; Humans; Injections, Intravenous; Male; Myocardial Perfusion Imaging; Organ Size; Radiopharmaceuticals; Rats, Sprague-Dawley; Risk Assessment; Rotenone; Time Factors; Tomography, Emission-Computed, Single-Photon; Toxicity Tests, Subacute | 2014 |
Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
Topics: alpha-Synuclein; Animals; Body Weight; Glutathione; HSP70 Heat-Shock Proteins; Male; Nerve Tissue Proteins; Oxidation-Reduction; Parkinson Disease; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Ubiquitin | 2014 |
Saxagliptin: a novel antiparkinsonian approach.
Topics: Adamantane; Animals; Antiparkinson Agents; Body Weight; Brain; Cathepsin C; Cyclic AMP; Dipeptides; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Gene Expression Regulation; Insecticides; Lipid Peroxidation; Male; Nerve Tissue Proteins; NF-E2-Related Factor 2; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Tyrosine 3-Monooxygenase | 2015 |
Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apomorphine; Body Weight; Brain; Disease Progression; Dopamine; Dopamine Agonists; Enteric Nervous System; Environmental Exposure; Housing, Animal; Male; Mice, Inbred C57BL; Motor Activity; Muscle, Skeletal; Neurons; Olfactory Perception; Parkinsonian Disorders; Rotenone; Tyrosine 3-Monooxygenase | 2015 |
Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease).
Topics: Animals; Antioxidants; Autophagy; Beclin-1; Body Weight; Catalepsy; Cognitive Dysfunction; Dopamine; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Gene Expression Regulation; Injections, Intraperitoneal; Male; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Quercetin; Rats; Rotenone; Signal Transduction; Thioredoxin-Disulfide Reductase; Transcription Factor CHOP | 2016 |
Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.
Topics: Alkaloids; Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Brain; Cell Line, Tumor; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Humans; In Situ Nick-End Labeling; Insecticides; L-Lactate Dehydrogenase; Male; MAP Kinase Signaling System; Mice; Monoamine Oxidase; Neuroblastoma; Neuroprotective Agents; Parkinson Disease, Secondary; Phenols; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Rotenone; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2017 |
Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study.
Topics: alpha-Synuclein; Animals; Body Weight; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mitochondria; Motor Activity; Neurons; Parkinsonian Disorders; Random Allocation; Rats, Wistar; Rotarod Performance Test; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo.
Topics: Animals; Body Weight; Cell Death; Dopamine; Electron Transport Complex I; Exploratory Behavior; gamma-Aminobutyric Acid; Gene Expression; Gene Expression Profiling; Male; Mitochondria; Neurons; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Rats; RNA, Messenger; Rotenone; Substantia Nigra; Transcriptional Activation | 2009 |
Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.
Topics: alpha-Synuclein; Animals; Body Weight; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; ELAV Proteins; ELAV-Like Protein 3; Formates; Gastrointestinal Diseases; Gastrointestinal Motility; Insecticides; Male; Neurons; Parkinson Disease; Rats; Rats, Inbred Lew; Rotenone; Statistics, Nonparametric | 2009 |
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
Topics: Animals; Body Weight; Cell Count; Cell Death; Corpus Striatum; Disease Models, Animal; Dopamine; Melatonin; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Random Allocation; Rats; Rats, Inbred Lew; Rotenone; Substantia Nigra; Survival Analysis; Tyrosine 3-Monooxygenase | 2010 |
Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.
Topics: Amacrine Cells; Animals; Blotting, Western; Body Weight; Dopaminergic Neurons; Electroretinography; Immunohistochemistry; Mitochondria; Nerve Degeneration; Neurotoxicity Syndromes; Photoreceptor Cells; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Rotenone; Synapses; Uncoupling Agents | 2011 |
Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Calcium-Binding Proteins; CD11b Antigen; Dopaminergic Neurons; Drug Synergism; Electron Transport Complex I; Female; Infusions, Subcutaneous; Insecticides; Lipopolysaccharides; Male; Microfilament Proteins; Microscopy, Electron, Transmission; Motor Activity; Movement; Nerve Tissue Proteins; Pregnancy; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Rotenone; Stereotyped Behavior; Substantia Nigra; Vibrissae | 2011 |
Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment.
Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Cell Death; Dopaminergic Neurons; Male; Neostriatum; Oxytocin; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone | 2012 |
Rotenone-dependent changes of anterograde motor protein expression and mitochondrial mobility in brain areas related to neurodegenerative diseases.
Topics: Aging; Animals; Body Weight; Brain; Gene Expression Regulation; Kinesins; Mitochondria; Molecular Motor Proteins; Motor Activity; Neurodegenerative Diseases; Organ Specificity; Protein Transport; Rats; Rats, Inbred Lew; RNA, Messenger; Rotenone | 2013 |
1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Homovanillic Acid; Insecticides; Isoquinolines; Male; Nucleus Accumbens; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Survival Rate; Tetrahydroisoquinolines | 2003 |
A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease.
Topics: Animals; Body Weight; Calorimetry, Differential Scanning; Catalepsy; Chemical Phenomena; Chemistry, Physical; Disease Models, Animal; Drug Delivery Systems; Immunohistochemistry; Microscopy, Electron, Scanning; Microspheres; Parkinson Disease; Particle Size; Rats; Rats, Sprague-Dawley; Rotenone; Tyrosine 3-Monooxygenase; X-Ray Diffraction | 2006 |
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Behavior, Animal; Benzothiazoles; Body Weight; Caspase 3; Caspases; Cell Death; Cerebral Cortex; Cytarabine; Diagnostic Imaging; Dopamine and cAMP-Regulated Phosphoprotein 32; Doxorubicin; Dystonia; Electron Transport Complex III; Enzyme Activation; Glial Fibrillary Acidic Protein; Immunohistochemistry; Locomotion; Male; Microscopy, Electron, Transmission; Mitochondria; Neurons; Phosphopyruvate Hydratase; Phosphorylation; Posture; Psychomotor Performance; Rats; Rats, Inbred Lew; Rotenone; tau Proteins; Tauopathies; Thiazoles; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase; Ubiquitin; Uncoupling Agents | 2005 |
Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats.
Topics: Analysis of Variance; Animals; Antioxidants; Body Weight; Drug Interactions; Gene Expression Regulation; Glutathione Peroxidase; Hypericum; Liposomes; Malondialdehyde; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rotenone; Superoxide Dismutase; Time Factors; Uncoupling Agents | 2007 |
Reproductive responses to rotenone during decidualized pseudogestation and gestation in rats.
Topics: Animals; Body Weight; Female; Fetal Resorption; Glycogen; Organ Size; Pregnancy; Pregnancy, Animal; Proteins; Pseudopregnancy; Rats; Rats, Inbred Strains; Rotenone; Uterus | 1982 |
Bioassay for carcinogenicity of rotenone in female Wistar rats.
Topics: Adenocarcinoma; Adenoma; Animals; Body Weight; Carcinogens; Chloroform; Cocarcinogenesis; Drug Interactions; Female; Fibroma; Mammary Neoplasms, Experimental; Rats; Rats, Wistar; Rotenone | 1993 |
Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone.
Topics: Adenoma; Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Carcinogens; Diethylnitrosamine; DNA; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Microbodies; Organ Size; Oxidation-Reduction; Pyrimidines; Rotenone | 1997 |
Effect of Tephrosia vogelii and Justicia extensa on Tilapia nilotica in vivo.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drug Stability; Hot Temperature; Plant Extracts; Plant Leaves; Rotenone; Tilapia; Time Factors | 2000 |
The development of mitochondrial oxidative enzymes in rat heart muscle.
Topics: Age Factors; Animals; Body Weight; Cell Membrane; Histocytochemistry; Male; Mitochondria, Muscle; Muscle Proteins; Myocardium; NADPH-Ferrihemoprotein Reductase; Organ Size; Rats; Rotenone; Succinate Cytochrome c Oxidoreductase | 1975 |
Toxicity and carcinogenicity of rotenone given in the feed to F344/N rats and B6C3F1 mice for up to two years.
Topics: Animals; Body Weight; Carcinogens; Diet; Eating; Female; Male; Mice; Mice, Inbred Strains; Parathyroid Neoplasms; Rats; Rats, Inbred F344; Rotenone; Sex Factors; Soft Tissue Neoplasms; Time Factors | 1988 |
Studies of steroid myopathy. Examination of the possible effect of triamcinolone on mitochondria and sarcotubular vesicles of rat skeletal muscle.
Topics: Adenine Nucleotides; Adenosine Triphosphatases; Aniline Compounds; Animals; Ascorbic Acid; Biological Transport; Body Weight; Calcium; Endoplasmic Reticulum; Female; Malates; Mitochondria, Muscle; Muscles; Muscular Atrophy; Oligomycins; Organ Size; Oxidative Phosphorylation; Oxygen Consumption; Polarography; Pyruvates; Rats; Rotenone; Succinates; Time Factors; Triamcinolone; Triamcinolone Acetonide; Uncoupling Agents | 1970 |
Inhibition of the growth of ehrlich ascites tumors by treatment with the respiratory inhibitor rotenone.
Topics: Animals; Body Weight; Carcinoma, Ehrlich Tumor; Mice; Mitosis; Rotenone | 1973 |
Cytoprotective and anti-diabetic effects of Derris reticulata aqueous extract.
Topics: Animals; Blood Glucose; Body Weight; Cell Line; Cell Survival; Cytoprotection; Derris; Diabetes Mellitus, Experimental; Female; Glucose; Hypoglycemic Agents; Insulin-Secreting Cells; Intestinal Absorption; Male; Phytotherapy; Plant Extracts; Rats; Rats, Wistar | 2014 |